Reduction of renal function by newer nonsteroidal anti-inflammatory drugs

Robert P. Kimberly(Regeneron (United States)), Paul H. Plötz(National Institutes of Health), Harry R. Keiser(National Heart Lung and Blood Institute), Robert E. Bowden
The American Journal of Medicine
May 1, 1978
Cited by 221


Related Papers